Tumor immunology and immunotherapy of malignant disease: Part 1. 1978

R C Staab

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R C Staab
January 1979, Advances in experimental medicine and biology,
R C Staab
May 1977, The Laryngoscope,
R C Staab
January 1976, Journal of the Royal College of Surgeons of Edinburgh,
R C Staab
April 1976, Annals of internal medicine,
R C Staab
April 1985, Dermatologic clinics,
R C Staab
March 1973, Helvetica chirurgica acta,
R C Staab
November 2020, European journal of immunology,
R C Staab
December 1980, Transplantation proceedings,
Copied contents to your clipboard!